Employer record · Agoura Hills, CA · FY2021–FY2026

A2 Biotherapeutics, Inc.

    USCIS approval rateFY24–26 · 5 approved

    Certified LCAs
    5
    FY2024–FY2026
    USCIS approvals
    5
    3 new employment
    Denial rate
    0.0%
    FY2024–FY2026
    Median wage offered
    $107k
    certified LCAs

    Jobs not indexed yet

    Does A2 Biotherapeutics, Inc. sponsor H-1B visas?

    Yes — by its record, A2 Biotherapeutics, Inc. is a small-scale H-1B sponsor: it filed 5 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 5 USCIS H-1B petition approvals (3 for new employment). Its latest certified LCA in our data was decided May 7, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Updated · DOL OFLC LCA disclosure + USCIS H-1B Employer Data Hub

    Filings by fiscal year

    Certified LCAs per U.S. government fiscal year (Oct–Sep) — 7 since FY2020; the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.

    A2 Biotherapeutics, Inc. certified LCAs by fiscal year
    Fiscal yearcertified LCAsUSCIS approvalsApproval rate
    FY2122100%
    FY2421100%
    FY2522100%
    FY2612100%

    Occupations sponsored

    Occupation (SOC)LCAsMedian wage
    Molecular and Cellular Biologists 19-10295$107k

    Most-filed job titles

    1. CELLULAR BIOLOGIST (SCIENTIST II )2$106k
    2. Associate Scientist1$107k
    3. Research Associate II1$80k
    4. Scientist II1$146k

    LCAs per title and median wage offered.

    Where the jobs were

    1. California5 LCAs

    We haven't indexed A2 Biotherapeutics' jobs yet

    We read jobs straight from employers' own career sites and haven't added A2 Biotherapeutics' yet. Its H-1B record on this page comes from public DOL and USCIS data and is not affected.

    Also filed as

    • A2 BIOTHERAPEUTICS, INC. (USCIS)
    • A2 Biotherapeutics, Inc. (LCA)
    • A2 BIOTHERAPEUTICS INC (USCIS)
    • A2 BIOTHERAPEUTICS, INC (LCA)

    A2 Biotherapeutics, Inc. H-1B: questions people ask

    Does A2 Biotherapeutics, Inc. sponsor H-1B visas?

    Yes — by its record, A2 Biotherapeutics, Inc. is a small-scale H-1B sponsor: it filed 5 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 5 USCIS H-1B petition approvals (3 for new employment). Its latest certified LCA in our data was decided May 7, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Is A2 Biotherapeutics, Inc. still sponsoring H-1B in 2026?

    A2 Biotherapeutics, Inc. had 1 certified LCAs in FY2026 (Oct 2025–Sep 2026), fewer than the 2 in FY2025. The latest one in our data was decided May 7, 2026. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.

    How many H-1B petitions does A2 Biotherapeutics, Inc. get approved?

    USCIS recorded 5 approvals (3 for new employment, the rest continuing employment such as extensions and transfers) and 0 denials for A2 Biotherapeutics, Inc. in FY2024–FY2026 — a denial rate of 0.0%. Source: USCIS H-1B Employer Data Hub (first decisions).

    What is the H-1B salary at A2 Biotherapeutics, Inc.?

    The median wage offered on A2 Biotherapeutics, Inc.'s certified LCAs in FY2024–FY2026 was $107k a year. By job title: CELLULAR BIOLOGIST (SCIENTIST II ) $106k (2 LCAs), Associate Scientist $107k (1 LCAs) and Research Associate II $80k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.

    Which jobs does A2 Biotherapeutics, Inc. sponsor for H-1B?

    Its certified LCAs in FY2024–FY2026 were mostly for Molecular and Cellular Biologists (5).

    Where are A2 Biotherapeutics, Inc.'s H-1B jobs?

    By worksite on its certified LCAs (FY2024–FY2026): California (5).

    Is A2 Biotherapeutics, Inc. an H-1B dependent employer?

    No — its recent LCAs do not declare it H-1B dependent.

    Does A2 Biotherapeutics, Inc. have open jobs?

    We read jobs straight from employers' own career sites and haven't added A2 Biotherapeutics' yet.